Innovating Works

H2020

Cerrada
HORIZON-MISS-2023-CANCER-01-04
Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions
ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes
Sólo fondo perdido 6.0M €
Europeo
Mostrando 81 al 96 de 96 resultados
iBeCHANGE: IBeCHANGE - ADDRESSING PSYCHOSOCIAL AND LIFESTYLE RISK FACTORS TO PROMOTE PRIMARY CANCER PREVENTION:... ISTITUTO EUROPEO DI ONCOLOGIA SRL tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 "Europe’s Beating Cancer Plan set has ambitious goals addressing key behavioral risk factors for cancer development, such as tobacco (target...
2023-12-01 - 2028-11-30 | Financiado
GEMINI: Towards GEMINI: A Generation of Multi-scale Digital Twins of Ischaemic and Haemorrhagic Stroke Patie... STICHTING AMSTERDAM UMC tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-TOOL-05 GEMINI aims to deliver validated multi-organ and multi-scale computational models for treatment decision support and improved fundamental un...
2023-12-01 - 2029-11-30 | Financiado
EDiHTA: The first European Digital Health Technology Assessment framework co-created by all stakeholders alo... UNIVERSITA CATTOLICA DEL SACRO CUORE tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-IND-06 Digital health technologies (DHTs) are expected to improve both the quality and delivery of healthcare services for European societies while...
2023-11-28 - 2027-12-31 | Financiado
ORTHO-ALLO-UNION: ORTHOpaedic treatment with ALLOgenic combined ATMP in long bone fracture delayed UNION and non union... SERVICIO MADRILENO DE SALUD tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-TOOL-05 Bone fracture with delay or failure to heal is a condition with huge health impact. Although only a small proportion of long bone fractures...
2023-11-28 - 2028-11-30 | Financiado
EvaMobs: Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform UNIVERSIDADE NOVA DE LISBOA tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 With progress in globalization, expansion of human populations into natural habitats, and aggravation of climate change comes an increased r...
2023-11-23 - 2028-12-31 | Financiado
LWNVIVAT: Limiting West Nile Virus impact by novel vaccines and therapeutics approaches FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 West Nile virus (WNV) is considered one of the most widespread mosquito-borne viral disease in the world. While most of WNV infected individ...
2023-11-23 - 2027-11-30 | Financiado
MARVAX: Development of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reacti... BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 The frequency, magnitude, and geographical range of Marburg virus disease outbreaks are expanding, with recent cases emerging in Equatorial...
2023-11-23 - 2027-11-30 | Financiado
NAVIPP: New AntiVirals for Infections with Pandemic Potential EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 For infectious disease management and control, vaccines are considered golden countermeasures. but are not the most adequate tool for mitiga...
2023-11-22 - 2028-12-31 | Financiado
ERAMET: Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the... UNIVERSITE DE NAMUR ASBL tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-IND-06 ERAMET will provide an integrated approach for developers and regulators’ decision-making for paediatric and orphan drugs, centred on the dr...
2023-11-17 - 2027-12-31 | Financiado
Yellow4FLAVI: Deconstructing the protective immunity of yellow fever virus 17D to inform flavivirus vaccine design INSTITUT PASTEUR tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 While endemic to the tropics, flaviviruses like Zika, dengue, West Nile or yellow fever virus are re-emerging pathogens of global health con...
2023-11-14 - 2028-12-31 | Financiado
WAge: Healthy Working environments for all Ages An evidence driven framework SINTEF AS tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-ENVHLTH-02 The WAge project will develop and validate the first comprehensive framework for assessing and understanding the roles and interactions betw...
2023-11-14 - 2027-11-30 | Financiado
VICI-DISEASE: PROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AN... KOBENHAVNS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 The enormous health and economic impacts of epidemics and pandemics has become one of the defining public policy and health issues in Europe...
2023-11-13 - 2027-11-30 | Financiado
HORUS: Health Outcomes from Raised Urban Settings UNIVERSITAT DE VALÈNCIA (ESTUDI GENERAL) tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 NCDs, especially diabetes and cardiovascular diseases (CVDs), are the leading causes of morbidity and mortality worldwide. CVDs kill more pe...
2023-11-13 - 2026-11-30 | Financiado
INTERCAMBIO: Interventions to promote mental and physical health in changing working environments due to climate... FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-ENVHLTH-02 Work environments are rapidly changing in Europe. The COVID-19 pandemic resulted in an acceleration of a range of complex and multidimension...
2023-11-10 - 2028-12-31 | Financiado
EBV-MS: Targeting Epstein Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis HOGSKULEN PA VESTLANDET tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS). It constitutes the most comm...
2023-11-10 - 2028-11-30 | Financiado
EP PerMed: European Partnership for Personalised Medicine DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-CARE-08 EP PerMed is a new European Partnership dedicated to Personalised Medicine (PM). It supports PM-related R&I, but also facilitates and accele...
2023-11-01 - 2033-10-31 | Financiado